肿瘤微环境
CD44细胞
癌症研究
细胞外基质
细胞
生物
免疫系统
胰腺癌
自然杀伤细胞
癌症
免疫学
细胞生物学
体外
细胞毒性T细胞
生物化学
遗传学
作者
Zoe X. Malchiodi,Robert K. Suter,Atul Deshpande,Ivana Peran,Brent T. Harris,Anju Duttargi,Min-Ju Chien,Samika Hariharan,Lucia Wetherill,Sandra A. Jablonski,Won Jin Ho,Elana J. Fertig,Louis M. Weiner
标识
DOI:10.1101/2024.05.23.593868
摘要
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer. PDAC’s poor prognosis and resistance to immunotherapy are attributed in part to its dense, fibrotic tumor microenvironment (TME), which is known to inhibit immune cell infiltration. We recently demonstrated that PDAC patients with higher natural killer (NK) cell content and activation have better survival rates. However, NK cell interactions in the PDAC TME have yet to be deeply studied. We show here that NK cells are present and active in the human PDAC TME. Methods We used imaging mass cytometry (IMC) to assess NK cell content, function, and spatial localization in human PDAC samples. Then, we used CellChat, a tool to infer ligand-receptor interactions, on a human PDAC scRNAseq dataset to further define NK cell interactions in PDAC. Results Spatial analyses showed for the first time that active NK cells are present in the PDAC TME, and both associate and interact with malignant epithelial cell ducts. We also found that fibroblast-rich, desmoplastic regions limit NK cell infiltration in the PDAC TME. CellChat analysis identified that the CD44 receptor on NK cells interacts with PDAC extracellular matrix (ECM) components such as collagen, fibronectin and laminin expressed by fibroblasts and malignant epithelial cells. This led us to hypothesize that these interactions play roles in regulating NK cell motility in desmoplastic PDAC TMEs. Using 2D and 3D in vitro assays, we found that CD44 neutralization significantly increased NK cell invasion through matrix. Conclusions Targeting ECM-immune cell interactions may increase NK cell invasion into the PDAC TME. Graphical Abstract
科研通智能强力驱动
Strongly Powered by AbleSci AI